A national clinical trial is now underway to evaluate an investigational medicine to improve hand strength and walking ability in people living with cerebral palsy. To be eligible for this study, you must be between 18 and 70 years old and be able to walk 25 feet. Participation involves five visits to the clinic over approximately 31 days. To learn more about this trial and to find the clinical trial site nearest you, please visit www.clinicaltrials.gov and search “Acorda Cerebral Palsy.”
Disclaimer: By providing information about this clinical trial, the Cerebral Palsy International Research Foundation (CPIRF) does not also endorse Acorda or the therapy dalfampridine. CPIRF has no affiliation or relationship with Acorda. CPIRF works to provide knowledge of a range of cerebral palsy news and information, including medical research, as a resource for those living with CP.
Most treatments for cerebral palsy (CP) are initially directed toward children. What is not clearly established is the long- term effects of such treatments. Many appear helpful in the short term but prove to be disadvantageous in the long run. Selective dorsal rhizotomy (SDR) is a permanent, irreversible neurosurgical procedure for reducing spasticity in cerebral palsy. Parents contemplating SDR for their child would like assurance that that there will not be harmful complications from it as the child ages into adolescence and adulthood. We now have new evidence...
I am a 64 year old male living with cerebral palsy who would like to participate in the CP mobility treatment clinical trial. I live in Vienna, VA and can walk 25 feet easily. Please advise as to location of nearest trial site.
My daughter Brianne is 22 years old and is diagnosed with Cerebral palsy. She can walk 25 feet with the assistance of a walker. We live in the Chicago area and would be interested in the trial if she were eligible.
Thank you.